Cortexyme Inc.

💊 Neuropharmaceuticals· 📍 San Francisco, CA, USA

Overview

Cortexyme develops small-molecule therapeutics targeting bacterial pathogens linked to Alzheimer's disease neuroinflammation and neurodegeneration.

Paradox Biosciences

San Diego, CA

Axon Neurosciences

Bratislava, Slovakia

Neuros Life Sciences

San Diego, CA

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

China Accelerates Its Brain-Computer Interface Ambitions in a Major National Push

2026-09-05 · Industry

Tether Evo Tackles Brain-Computer Interface's Most Stubborn Engineering Problem

2026-09-04 · Research

FDA Grants De Novo Approval to Modius Spero, Clearing First Neuromodulation Device for PTSD

2026-09-03 · Policy

Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%

2026-09-02 · Industry

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Advertise

Newsletter sponsorships, featured listings, and sponsored articles.